| QIJ31525.1 |
Ctg1_35 |
BGC0002545.3 |
PKS |
34.0 |
83.1 |
151.0 |
2.42e-41 |
| CDG76950.1 |
permease_of_the_major_facilitator_superfamily_protein |
BGC0000446.5 |
NRPS:Type I |
29.0 |
92.3 |
135.0 |
1.73e-35 |
| ATJ04402.1 |
MFS_transporter |
BGC0001637.3 |
NRPS:Type I |
28.0 |
97.8 |
132.0 |
3.2e-34 |
| AAM54113.1 |
bicyclomycin_resistant_protein |
BGC0000020.3 |
PKS |
35.0 |
63.3 |
125.0 |
4.18e-32 |
| AWD37884.1 |
putative_siderophore_MFS_transporter_DfoS |
BGC0001572.3 |
other:other |
29.0 |
63.5 |
82.0 |
1.04e-16 |
| AFL48523.1 |
laidlomycin_efflux_protein |
BGC0000084.5 |
PKS |
31.0 |
39.2 |
65.0 |
6.25e-11 |
| AJI44184.1 |
drug_resistance_transporter_EmrB/QacA |
BGC0001193.5 |
NRPS:Type I |
29.0 |
42.4 |
64.0 |
8.55e-11 |
| AAQ08935.1 |
putative_membrane_transporter |
BGC0000224.4 |
PKS:Type II |
32.0 |
34.0 |
62.0 |
6.23e-10 |
| AEI98661.1 |
CtcR |
BGC0000209.5 |
PKS |
33.0 |
49.4 |
61.0 |
8.03e-10 |
| WP_002277502.1 |
DHA2_family_efflux_MFS_transporter_permease_subunit |
BGC0002058.3 |
PKS+NRPS:Type I |
29.0 |
33.7 |
57.0 |
2.62e-08 |
| QCY50746.1 |
DHA2_family_efflux_MFS_transporter_permease_subunit |
BGC0002287.2 |
NRPS:Type I |
29.0 |
33.7 |
57.0 |
2.62e-08 |
| OKI81366.1 |
EmrB/QacA_family_drug_resistance_transporter |
BGC0002478.3 |
PKS |
28.0 |
29.0 |
56.0 |
5.46e-08 |
| ADZ13560.1 |
YtkR6 |
BGC0000466.5 |
NRPS:Type I |
27.0 |
38.7 |
55.0 |
9.01e-08 |
| QOV03401.1 |
SpoC |
BGC0002262.2 |
PKS |
29.0 |
39.5 |
52.0 |
5.3e-07 |
| ABS50496.1 |
NapR6 |
BGC0000652.5 |
terpene |
25.0 |
46.9 |
52.0 |
7.22e-07 |
| ABS50468.1 |
NapR6 |
BGC0001079.5 |
PKS:Type III+terpene:Monoterpene |
25.0 |
46.9 |
52.0 |
7.22e-07 |
| OSS48493.1 |
hypothetical_protein |
BGC0002194.3 |
PKS |
28.0 |
36.0 |
52.0 |
7.5e-07 |
| WP_079179220.1 |
MFS_transporter |
BGC0001819.3 |
PKS |
30.0 |
41.7 |
50.0 |
3.6e-06 |